US · Healthcare

Neurocrine Biosciences Inc (NBIX)

Drug Manufacturers - Specialty & Generic

Neurocrine Biosciences Inc (NBIX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NBIX

P/E ratio

18.00

Neurocrine Biosciences Inc (NBIX) — FAQ

What is NBIX's P/E ratio?

The price-to-earnings (P/E) ratio for Neurocrine Biosciences Inc (NBIX) is 18.00 (data as of 2026-03-24).

Does Neurocrine Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Neurocrine Biosciences Inc (NBIX). Check the MyAverix Finance app for the latest dividend data.

What sector is Neurocrine Biosciences Inc in?

Neurocrine Biosciences Inc (NBIX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is NBIX listed on?

NBIX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)